+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiac Marker Testing Market by Marker Type (Ck-Mb, Ldh, Myoglobin), Product (Assay Kits, Instruments, Reagents), Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995396
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiac marker testing market is undergoing rapid transformation, powered by groundbreaking diagnostic technologies, new clinical protocols, and evolving supply chain dynamics. Focused on providing actionable intelligence for senior decision-makers, this report distills a complex landscape into clear insights on opportunities, risks, and strategic imperatives for growth.

Market Snapshot: Cardiac Marker Testing Market Overview

The cardiac marker testing market grew from USD 5.50 billion in 2024 to USD 5.95 billion in 2025. It is expected to continue growing at a CAGR of 7.92%, reaching USD 8.69 billion by 2030. This growth is driven by rising cardiovascular disease incidence, relentless technological innovation, and the shift towards early disease detection and personalized patient management. Regulatory changes and advancements in both central laboratory and point-of-care testing are extending market reach across global healthcare segments.

Scope & Segmentation: Cardiac Marker Testing Market Coverage

  • Marker Types: Ck-Mb, Ldh, Myoglobin, Troponin I (Conventional, High Sensitivity), Troponin T (Conventional, High Sensitivity)
  • Products: Assay Kits (Multiplex Kits, Single Analyte Kits), Instruments (Bench Top Analyzers, Handheld Devices), Reagents (Bulk Reagents, Ready To Use Reagents)
  • Technologies: Immunoassay (Chemiluminescence Immunoassay, Elisa), Lab Automation (Semi Automated Analyzers, Walkaway Systems), Point Of Care (Biosensor Based Devices, Lateral Flow Immunoassay)
  • End Users: Clinics (Cardiac Clinics, Outpatient Clinics), Diagnostic Labs, Hospitals (Community Hospitals, Tertiary Hospitals)
  • Geographic Regions: Americas (United States including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Analyzed: F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Ortho Clinical Diagnostics Inc., Quidel Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Adoption of high-sensitivity cardiac biomarker assays is transforming clinical protocols, enabling earlier and more precise diagnosis of myocardial injury.
  • The integration of point-of-care testing with digital health is accelerating, supporting faster care decisions outside conventional hospital laboratories.
  • Automation and workflow standardization are critical as testing volumes rise, with laboratories prioritizing throughput, data quality, and operational efficiency.
  • Industry partnerships between technology developers, reagent suppliers, and healthcare providers are fueling innovation in marker validation and workflow optimization.
  • Regional dynamics highlight the need for tailored go-to-market strategies, with each geography driving adoption through unique health system strengths and regulatory landscapes.
  • Emerging companies are introducing compact, biosensor-based platforms, intensifying competition and diversifying market offerings.

Tariff Impact: 2025 US Trade Policies and Market Resilience

New United States tariffs on imported reagents and assay components have prompted manufacturers to adapt sourcing and supply chain strategies. Firms are exploring nearshoring, domestic production, and collaborative partnerships to manage regulatory compliance and continuity. The shift is requiring capital investment but aims to sustain consistent product availability for critical diagnostic workflows nationwide.

Methodology & Data Sources

This report uses a rigorous, multi-tiered research methodology. Primary insights were gathered from interviews with industry leaders and clinicians, supplemented by secondary research from regulatory filings and peer-reviewed literature. All data and trends underwent expert panel review to ensure analytical accuracy and actionable recommendations.

Why This Report Matters: Decision-Ready Guidance

  • Empowers executives with market trends and segmented opportunity analysis aligned to regulatory and technological evolutions.
  • Equips operational and strategic leaders with clarity on innovation pipelines, global adoption patterns, and emerging challenges shaping cardiac diagnostics.

Conclusion

The cardiac marker testing market is poised for sustained evolution, shaped by innovation, shifting healthcare priorities, and complex regulatory factors. Stakeholders that align strategy to technological and regional trends will be best positioned to drive growth and maximize clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of high-sensitivity cardiac troponin assays in point-of-care settings across emergency departments enabling faster diagnosis
5.2. Integration of AI-driven data analytics with cardiac marker testing platforms to improve predictive accuracy and personalized treatment strategies
5.3. Growing demand for multiplexed biomarker panels combining troponin, BNP, and myoglobin for comprehensive cardiac event risk stratification
5.4. Expansion of remote patient monitoring devices with wireless cardiac marker detection for early intervention in heart failure management
5.5. Regulatory approvals driving increased availability of rapid immunoassays for cardiac markers in emerging markets across Asia-Pacific and Latin America
5.6. Strategic partnerships between diagnostics companies and digital health firms to develop cloud-based cardiac marker surveillance solutions
5.7. Emergence of novel biomarker discovery pipelines focusing on microRNA and inflammatory markers complementing traditional cardiac marker assays
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Marker Testing Market, by Marker Type
8.1. Introduction
8.2. Ck-Mb
8.3. Ldh
8.4. Myoglobin
8.5. Troponin I
8.5.1. Conventional Troponin I
8.5.2. High Sensitivity Troponin I
8.6. Troponin T
8.6.1. Conventional Troponin T
8.6.2. High Sensitivity Troponin T
9. Cardiac Marker Testing Market, by Product
9.1. Introduction
9.2. Assay Kits
9.2.1. Multiplex Kits
9.2.2. Single Analyte Kits
9.3. Instruments
9.3.1. Bench Top Analyzers
9.3.2. Handheld Devices
9.4. Reagents
9.4.1. Bulk Reagents
9.4.2. Ready To Use Reagents
10. Cardiac Marker Testing Market, by Technology
10.1. Introduction
10.2. Immunoassay
10.2.1. Chemiluminescence Immunoassay
10.2.2. Elisa
10.3. Lab Automation
10.3.1. Semi Automated Analyzers
10.3.2. Walkaway Systems
10.4. Point Of Care
10.4.1. Biosensor Based Devices
10.4.2. Lateral Flow Immunoassay
11. Cardiac Marker Testing Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Cardiac Clinics
11.2.2. Outpatient Clinics
11.3. Diagnostic Labs
11.4. Hospitals
11.4.1. Community Hospitals
11.4.2. Tertiary Hospitals
12. Americas Cardiac Marker Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cardiac Marker Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cardiac Marker Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche AG
15.3.2. Abbott Laboratories
15.3.3. Siemens Healthineers AG
15.3.4. Danaher Corporation
15.3.5. Thermo Fisher Scientific Inc.
15.3.6. bioMérieux SA
15.3.7. Ortho Clinical Diagnostics Inc.
15.3.8. Quidel Corporation
15.3.9. Becton, Dickinson and Company
15.3.10. Bio-Rad Laboratories, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CARDIAC MARKER TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CARDIAC MARKER TESTING MARKET: RESEARCHAI
FIGURE 24. CARDIAC MARKER TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. CARDIAC MARKER TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. CARDIAC MARKER TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CK-MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CK-MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LDH, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LDH, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONVENTIONAL TROPONIN I, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONVENTIONAL TROPONIN I, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HIGH SENSITIVITY TROPONIN I, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HIGH SENSITIVITY TROPONIN I, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONVENTIONAL TROPONIN T, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONVENTIONAL TROPONIN T, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HIGH SENSITIVITY TROPONIN T, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HIGH SENSITIVITY TROPONIN T, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MULTIPLEX KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MULTIPLEX KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY SINGLE ANALYTE KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY SINGLE ANALYTE KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BENCH TOP ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BENCH TOP ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BULK REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BULK REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY READY TO USE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY READY TO USE REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY SEMI AUTOMATED ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY SEMI AUTOMATED ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY WALKAWAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY WALKAWAY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOSENSOR BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOSENSOR BASED DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 168. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 169. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 170. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 171. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 174. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 175. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 176. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 177. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 178. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 179. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 182. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 183. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 185. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 186. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 187. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 190. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 191. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 196. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 197. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 198. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 199. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 200. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 201. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Ortho Clinical Diagnostics Inc.
  • Quidel Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.

Table Information